MedTrace Logo

Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours

NCT04225767 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2022-12-13

No results posted yet for this study

Summary

Phase II Investigation of Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours.

Conditions

Interventions

COMBINATION_PRODUCT

Calcium electroporation

Patients with cutaneous or subcutaneous malignant tumours will be treated with calcium electroporation, i.e. intratumoral injection of calcium followed by electroporation by electric pulses applied directly to the tumor.

Sponsors & Collaborators

  • Vejle Hospital

    collaborator OTHER

  • University College Absalon

    collaborator OTHER

  • University Hospital Schleswig-Holstein

    collaborator OTHER

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Julie Gehl, MD · Zealand University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-18
Primary Completion
2023-01-01
Completion
2023-08-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04225767 on ClinicalTrials.gov